$599

Novo Launches Novocare 2.0; Tryngolza sHTG EU Approval; MiniMed Flex EU Launch

Three cardiometabolic-related news items have been observed: Novo launched Novocare 2.0 with a new app (view press release); Ionis/Sobi received EC approval of Tryngolza for sHTG in the EU (view Ionis press release; view Sobi press release); and MiniMed launched Flex in the EU (view press release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here